Cite
HARVARD Citation
Cook, A. et al. (2021). Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab. Respirology case reports. 9 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cook, A. et al. (2021). Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab. Respirology case reports. 9 (5), p. n/a. [Online].